Acute myocardial infarction following allogeneic hematopoietic stem cell transplantation: A national cohort study.

Saved in:
Bibliographic Details
Title: Acute myocardial infarction following allogeneic hematopoietic stem cell transplantation: A national cohort study.
Authors: Zhao P; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China; . National Clinical Research Center for Hematologic Disease, Beijing, China; . Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China., Li ZX; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China; . National Clinical Research Center for Hematologic Disease, Beijing, China; . Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China., Jiang EL; State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China., Fan SJ; Division of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, China., Liu DH; Senior Department of Hematology, The Fifth Medical Center of Chinese People's Liberation Army (PLA) General Hospital, Beijing, China., He PC; Department of Hematology, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China., Yan JS; Second Hospital of Dalian Medical University, Dalian, China., Jiang M; Blood Disease Center, First Affiliated Hospital of Xinjiang Medical University, Urumqi, China., Xu YJ; Department of Hematology, Xiangya Hospital, Central South University, Changsha, China., Xia LH; Institute of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China., Ren JH; Hematology Department, The Second Hospital of Hebei Medical University, Shijiazhuang, China., Zhang HY; Department of Hematology, Peking University Shenzhen Hospital, Shenzhen, China., Dong YJ; Department of Hematology, Peking University First Hospital, Beijing, China., Wang WD; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Liang Y; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China., Fu HX; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China; . National Clinical Research Center for Hematologic Disease, Beijing, China; . Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China., Huang QS; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China; . National Clinical Research Center for Hematologic Disease, Beijing, China; . Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China., Wu J; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China; . National Clinical Research Center for Hematologic Disease, Beijing, China; . Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China., An ZY; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China; . National Clinical Research Center for Hematologic Disease, Beijing, China; . Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China., Jin Y; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China; . National Clinical Research Center for Hematologic Disease, Beijing, China; . Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China., Yang LP; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China; . National Clinical Research Center for Hematologic Disease, Beijing, China; . Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China., Wang CC; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China; . National Clinical Research Center for Hematologic Disease, Beijing, China; . Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China., He Y; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China; . National Clinical Research Center for Hematologic Disease, Beijing, China; . Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China., Zhu XL; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China; . National Clinical Research Center for Hematologic Disease, Beijing, China; . Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China., Chen Q; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China; . National Clinical Research Center for Hematologic Disease, Beijing, China; . Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China., Zhang YY; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China; . National Clinical Research Center for Hematologic Disease, Beijing, China; . Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China., Mo XD; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China; . National Clinical Research Center for Hematologic Disease, Beijing, China; . Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China., Chang YJ; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China; . National Clinical Research Center for Hematologic Disease, Beijing, China; . Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China., Wang Y; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China; . National Clinical Research Center for Hematologic Disease, Beijing, China; . Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China., Xu LP; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China; . National Clinical Research Center for Hematologic Disease, Beijing, China; . Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China., Zhao XY; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China; . National Clinical Research Center for Hematologic Disease, Beijing, China; . Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China., Liu KY; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China; . National Clinical Research Center for Hematologic Disease, Beijing, China; . Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China., Huang XJ; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China; . National Clinical Research Center for Hematologic Disease, Beijing, China; . Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China; . Peking-Tsinghua Center for Life Sciences, Beijing, China., Zhang XH; Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China; . National Clinical Research Center for Hematologic Disease, Beijing, China; . Beijing Key Laboratory of Cell and Gene Therapy for Hematologic Malignancies, Peking University, Beijing, China. Electronic address: zhangxh@bjmu.edu.cn.
Source: Cancer letters [Cancer Lett] 2026 Apr 01; Vol. 642, pp. 218287. Date of Electronic Publication: 2026 Jan 31.
Publication Type: Journal Article; Multicenter Study
Journal Info: Publisher: Elsevier Science Ireland Country of Publication: Ireland NLM ID: 7600053 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1872-7980 (Electronic) Linking ISSN: 03043835 NLM ISO Abbreviation: Cancer Lett Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1872-7980
DOI:10.1016/j.canlet.2026.218287